ArticleDiscover oncology2024

Anlotinib inhibits growth of human esophageal cancer TE-1 cells by negative regulating PI3K/Akt signaling pathway.

Yueli Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.